Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy

por Winthrop, Kevin L., Bingham, Clifton O., Komocsar, Wendy J., Bradley, John, Issa, Maher, Klar, Rena, Kartman, Cynthia E.
Publicado 2019

Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study

por Takeuchi, Tsutomu, Genovese, Mark C, Haraoui, Boulos, Li, Zhanguo, Xie, Li, Klar, Rena, Pinto-Correia, Ana, Otawa, Susan, Lopez-Romero, Pedro, de la Torre, Inmaculada, Macias, William, Rooney, Terence P, Smolen, Josef S
Publicado 2019

Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic d...

por van der Heijde, Desirée, Dougados, Maxime, Chen, Ying-Chou, Greenwald, Maria, Drescher, Edit, Klar, Rena, Xie, Li, de la Torre, Inmaculada, Rooney, Terence P, Witt, Sarah L, Schlichting, Douglas E, de Bono, Stephanie, Emery, Paul
Publicado 2018